Mr. Meni Morim reports

LIFEIST'S MIKRA COMPLETES FORMULATION OF INNOVATIVE MENTAL HEALTH PRODUCT FOR ANXIETY

Lifeist Wellness Inc.'s U.S. biosciences subsidiary Mikra Cellular Sciences Inc. has completed the formulation and commenced production of a new and innovative supplement aimed at supporting the widespread modern struggle with anxiety. Serenity is a natural supplement containing a precise GCMS-verified (gas chromatography mass spectrometry) dose of extract of lavender oil, formulated based on extensive studies, including randomized, double-blind trials, with the results published in peer-reviewed clinical research.

"Serenity is a significant addition to our product portfolio, representing our dedication to addressing the pressing health concerns of the modern age," said Meni Morim, chief executive officer of Lifeist Wellness. "By skillfully integrating our proprietary polyterpene blend, we've refined the flavour profile to deliver an unmatched experience. This innovation complements our successful Cellf product, reflecting our commitment to advancing holistic wellness solutions.

"Anxiety disorders are widespread, affecting 40 million adults in the U.S. alone, yet a significant portion of this population remains untreated. Serenity is based on extensive research and aligns with the contemporary shift towards natural approaches," Mr. Morim continued. "With less than 37 per cent of those affected seeking treatment, we recognize the need for natural, accessible and palatable supplements. By leveraging our nutraceutical expertise, we are proud to bring to market a supplement that is firmly based on science. Serenity is poised to make a meaningful impact in enhancing mental well-being, aligning with our vision of improving lives through cellular health."

The market opportunity for Serenity is substantial, given that anxiety disorders represent the most prevalent mental health concern in the United States, impacting approximately 40 million adults accounting for about 19.1 per cent of the adult population. While these disorders are generally treatable, fewer than 37 per cent of those affected seek or receive treatment.

Two of the most prescribed treatments for anxiety disorders are selective serotonin reuptake inhibitors (SSRIs), such as Prozac, Paxil and Lexapro, and benzodiazepines, like Xanax. However, both categories of treatments may come with potentially substantial adverse effects. SSRIs can lead to issues like weight gain and sexual dysfunction, while benzodiazepines are known for their strong potential for habit-forming and can even cause seizures during withdrawal.

Serenity has been formulated based on lavender, a natural botanical extract, aligning with Mikra's core commitment to enhancing lives through natural ingredients, the power of science and a focus on cellular health. Lavender oil extract has undergone thorough evaluation in randomized, double-blind clinical trials, where it demonstrated notable effectiveness even surpassing that of paroxetine (Paxil), a leading SSRI recommended for managing generalized anxiety disorder. This study's findings indicated that lavender oil extract is both efficacious and well tolerated in patients with generalized anxiety disorder (GAD), enabling termination after a 10-week treatment at the full therapeutic dose without down-titration and without inducing withdrawal symptoms. In Europe, lavender oil extract has gained prominence as a primary, first-line strategy in addressing anxiety-related concerns and has secured widespread approval for this purpose.

What sets Serenity apart is the GCMS-verified precision of the active ingredient dosage, and the incorporation of Mikra's proprietary polyterpene blend, meticulously crafted to deliver a pleasing flavour profile and address the common concern raised by initial users of other oral lavender products regarding their perfume-like taste and aftertaste. Capitalizing on the Lifeist team's experience with fragrant and flavourful botanicals, Serenity is poised to be among the most palatable lavender oil extract supplements on the market, with the most consistent, reliably precise dose every time.

Mikra is pushing biosciences beyond the expected with the belief that it is possible to add more vigorous, active, valuable and enjoyable years to your life through protecting and maintaining your cellular health. Mikra takes pride in introducing Serenity, which will be available for sale on Mikra's website before the December holiday season.

About Lifeist Wellness Inc.

Sitting at the forefront of the postpandemic wellness revolution, Lifeist leverages advancements in science and technology to build breakthrough companies that transform human wellness. Portfolio business units include: CannMart, which operates a business-to-business wholesale distribution business facilitating recreational cannabis sales to Canadian provincial government control boards, including for CannMart Labs, a BHO extraction facility producing high-margin cannabis 2.0 products; Australian Vapes, one of Australia's largest on-line retailers of vaporizers and accessories; and Mikra, a biosciences and consumer wellness company developing and selling innovative therapies for cellular health.

We seek Safe Harbor.